Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma.

MLA

Haque, Waqar, et al. “Prognostic and Predictive Impact of MGMT Promoter Methylation Status in High Risk Grade II Glioma.” Journal of Neuro-Oncology, vol. 157, no. 1, Mar. 2022, pp. 137–46. EBSCOhost, https://doi.org/10.1007/s11060-022-03955-3.

APA

Haque, W., Teh, C., Butler, E. B., & Teh, B. S. (2022). Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma. Journal of Neuro-Oncology, 157(1), 137–146. https://doi.org/10.1007/s11060-022-03955-3

Chicago

Haque, Waqar, Caitlyn Teh, E. Brian Butler, and Bin S. Teh. 2022. “Prognostic and Predictive Impact of MGMT Promoter Methylation Status in High Risk Grade II Glioma.” Journal of Neuro-Oncology 157 (1): 137–46. doi:10.1007/s11060-022-03955-3.